<code id='F52877D297'></code><style id='F52877D297'></style>
    • <acronym id='F52877D297'></acronym>
      <center id='F52877D297'><center id='F52877D297'><tfoot id='F52877D297'></tfoot></center><abbr id='F52877D297'><dir id='F52877D297'><tfoot id='F52877D297'></tfoot><noframes id='F52877D297'>

    • <optgroup id='F52877D297'><strike id='F52877D297'><sup id='F52877D297'></sup></strike><code id='F52877D297'></code></optgroup>
        1. <b id='F52877D297'><label id='F52877D297'><select id='F52877D297'><dt id='F52877D297'><span id='F52877D297'></span></dt></select></label></b><u id='F52877D297'></u>
          <i id='F52877D297'><strike id='F52877D297'><tt id='F52877D297'><pre id='F52877D297'></pre></tt></strike></i>

          comprehensive

          comprehensive

          author:leisure time    Page View:52329
          Two business miniatures talk to each other on coin stacks that are sandwiched by a syringe and a stethoscope — coverage from STAT
          Adobe

          For all the flak they get, the country’s four biggest pharmacy benefit managers reported a surprisingly tame average profit margin in the first three quarters of 2023: 4.5%, less than a third of their drugmaker peers.

          But don’t take their numbers as gospel, experts warned.

          advertisement

          “It’s really easy to move money around inside the books of a vertically integrated organization,” said Karen Van Nuys, a senior fellow at the USC Schaeffer Center for Health Policy and Economics. “If one segment of your vertically integrated organization is not publishing any financial data, it’s a good place to hide stuff.”

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Medical records are filled with copy
          Medical records are filled with copy

          AdobeIrecentlytookcareofapatientwhosemedicalrecordsincludedmultiplenotesaboutherpastopen-heartsurger

          read more
          Dispute over threat of extinction posed by artificial intelligence looms over surging industry
          Dispute over threat of extinction posed by artificial intelligence looms over surging industry

          5:08Advancedhumanoidrobot'Sophia'ispicturedatAIforGoodGlobalSummit,inGeneva,Switzerland,July6,2023.P

          read more
          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more

          EMA weighs against approval for Mirati's lung cancer drug

          AdobeAEuropeanregulatorypanelhasrecommendedagainstapprovalofalungcancerdrugmadebyMiratiTherapeutics,